“Klinisch bedeutsame” neue Arzneimittelinteraktionen“Clinically relevant” new drug interactions

被引：0
|
作者：
Uwe Fuhr
机构：
[1] Institut für Pharmakologie der Universität,Klinische Pharmakologie
来源：
Medizinische Klinik | 1999年 / 94卷 / 2期
关键词：
Arzneimittelinteraktionen; Selektive Serotoninwiederaufnahmehemmer; HMG-CoA-Reduktasehemmer; Mibefradil; Sildenafil; Proteasehemmer; Grapefruitsaft; Drug interactions; Selective serotonin re-uptake inhibitors; HMG-CoA reductase inhibitors; Mibefradil; Sildenafil; Protease inhibitors; Grapefruit juice;
D O I：
10.1007/BF03044714
中图分类号：
学科分类号：
摘要：
□ Die gleichzeitige Einnahme von Arzneistoffen mit einem Interaktionspotential ist häufig. Dagegen machen unerwünschte Wirkungen aufgrund von Arzneimittelinteraktionen nur einen Bruchteil aller unerwünschten Wirkungen aus.
引用
收藏
页码：120 / 124
页数：4
相关论文
共 50 条
  • [41] DGIdb 2.0: mining clinically relevant drug-gene interactions
    Wagner, Alex H.
    Coffman, Adam C.
    Ainscough, Benjamin J.
    Spies, Nicholas C.
    Skidmore, Zachary L.
    Campbell, Katie M.
    Krysiak, Kilannin
    Pan, Deng
    McMichael, Joshua F.
    Eldred, James M.
    Walker, Jason R.
    Wilson, Richard K.
    Mardis, Elaine R.
    Griffith, Malachi
    Griffith, Obi L.
    NUCLEIC ACIDS RESEARCH, 2016, 44 (D1) : D1036 - D1044
  • [42] Clinically relevant drug interactions with orally administered targeted antitumor agents
    Lipp, H. -P.
    ONKOLOGE, 2013, 19 (10): : 870 - 877
  • [43] Clinically relevant drug interactions between anticancer drugs and psychotropic agents
    Yap, K. Y. -L.
    Tay, W. L.
    Chui, W. K.
    Chan, A.
    EUROPEAN JOURNAL OF CANCER CARE, 2011, 20 (01) : 6 - 32
  • [44] Clinically relevant drug interactions between newer antidepressants and oral anticoagulants
    Spina, Edoardo
    Barbieri, Maria Antonietta
    Cicala, Giuseppe
    Bruno, Antonio
    de Leon, Jose
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (01) : 31 - 44
  • [45] Clinically Relevant Pharmacokinetic Herb-drug Interactions in Antiretroviral Therapy
    Fasinu, Pius S.
    Gurley, Bill J.
    Walker, Larry A.
    CURRENT DRUG METABOLISM, 2016, 17 (01) : 52 - 64
  • [46] Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs
    Caraci, Filippo
    Sultana, Janet
    Drago, Filippo
    Spina, Edoardo
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2017, 16 (04) : 501 - 513
  • [47] Letter to the Editor: Clinically relevant drug–drug interactions among elderly people with dementia
    Eva Sönnerstam
    Maria Sjölander
    Hugo Lövheim
    Maria Gustafsson
    European Journal of Clinical Pharmacology, 2019, 75 : 1321 - 1322
  • [48] Letter to editor: Clinically relevant drug–drug interactions among elderly people with dementia
    Carmen Aranda-Salazar
    Jean Mendoza-Ramos
    Alonso Soto
    European Journal of Clinical Pharmacology, 2019, 75 : 1319 - 1319
  • [49] Coadministration of Dalcetrapib With Pravastatin, Rosuvastatin, or Simvastatin: No Clinically Relevant Drug-Drug Interactions
    Derks, Michael
    Abt, Markus
    Phelan, Mary
    Turnbull, Lynn
    Meneses-Lorente, Georgina
    Bech, Nuria
    White, Anne-Marie
    Parr, Graeme
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (10): : 1188 - 1201
  • [50] Evaluation of Safety and Clinically Relevant Drug-Drug Interactions with Tucatinib in Healthy Volunteers
    Topletz-Erickson, Ariel
    Lee, Anthony
    Rustia, Evelyn L.
    Sun, Hao
    Mayor, JoAl G.
    Abdulrasool, Layth, I
    Walker, Luke
    Endres, Christopher J.
    CLINICAL PHARMACOKINETICS, 2022, 61 (10) : 1417 - 1426
12345